By Marisa Taylor Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives. Over the past two years, more than 200 patients have flocked to see Dr. Green after learning that two drugs he prescribes could possibly stave off aging.
Lilly has released Lispro, a generic form of its insulin drug of Humalog, cutting the list price in half and ideally reducing out-of-pocket patient costs. Insulin Lispro will go for $137.35 per vial or $265.50 for a pack of five KwikPens. Because Humalog and Lispro are fast-acting forms of insulin,
By Shefali Luthra Democrats with 2020 presidential aspirations are courting the party’s increasingly influential progressive wing and staking out ambitious policy platforms. Front and center are three words: Medicare. For. All. That simple phrase is loaded with political baggage, and often accompanied by vague promises and complex jargon. Different candidates use
As a federal judge reviews the merger between CVS Health and Aetna, the Department of Justice is sticking by its agreement with the two companies, according to an article in FierceHealthcar Feb 19. In a court filing in mid-February, DOJ defended that deal. Judge Richard J. Leon of the U.S. District Court
If you are a physician specializing in interventional cardiology, interventional radiology or vascular surgery — or a non-physician employed or affiliated with a corporation involved in providing patients with endovascular and interventional procedures, you will find the OEIS’s 6th Annual National Scientific Meeting April 5-6 in St. Petersburg, Florida,